Det fremstilles af en bakterie, der har modtaget et gen (DNA), der sætter den i stand til at producere insulin lispro.
The active substance in Liprolog, insulin lispro, is produced by a method known as ‘ recombinant DNA technology’: it is made by a bacterium that has received a gene (DNA), which makes it able to produce insulin lispro.